Body-Identical HRT
Also known as: Bioidentical HRT, Regulated bioidentical HRT
Refers to HRT using hormones with a molecular structure identical to those produced by the human body — primarily 17β-estradiol and micronized progesterone. These are available as licensed products (patches, gels, Utrogestan) on the NHS and are distinct from unregulated 'compounded bioidentical HRT'. NICE and BMS endorse body-identical regulated HRT as the preferred approach.
This page contains self-reported experiences from the Narrated community — not clinical data. Outcomes are subjective. Always consult your doctor or specialist before starting, stopping, or changing any approach.
Regulatory status is factual context, not a clinical-risk assessment. Laws vary by country.
Community Experiences
0 reports from women who tried Body-Identical HRT
No one has reported on this approach yet.
Be the first to share an experience.
Research Context
Research context compiled from published sources
How does Body-Identical HRT work?
Uses 17β-estradiol and micronized progesterone, which bind to oestrogen and progesterone receptors with the same affinity as endogenous hormones. Considered to have a more favourable safety profile than older synthetic hormone formulations, particularly regarding breast cancer and cardiovascular risk.
Research Depth
Well Studied
Extensive human research over many years, including randomized controlled trials.
Long-Term Evidence
Well Characterized
Decades of long-term human-use data are available.
Known Interactions
Reported Contraindicated Populations
Published Dose Ranges
Dose ranges from published research. Individual dosing is context-specific and belongs in a healthcare conversation.
Factual research context from published sources — not a clinical-risk assessment or guidance. Research classifications may change as new data emerges.
Related Approaches
Other approaches tracked on Narrated.
Data last updated: No data yet